Unlike large pharma where novel projects compete with established, safer alternatives, biotech startups derive immense power from their singular focus. The "live or die" mentality on a single hard problem forces teams to innovate and persevere through setbacks, which is essential for pushing true scientific boundaries.

Despite resource constraints, startups can be better environments for long-term, focused research. Unlike large frontier labs where strategic priorities can shift unexpectedly for political or market reasons, a startup's singular mission allows for sustained effort on a hard problem.

Training in a resource-constrained Irish lab taught deep, focused thinking and prioritization—essential for running a lean startup. Conversely, a well-funded Boston lab enabled large-scale, exploratory science leading to breakthroughs. Hegarty credits this dual experience for his success in both academic discovery and biotech leadership.

The transition from academia to entrepreneurship is most successful when the focus shifts from pure science or technology to solving a tangible, pre-existing clinical problem. This ensures market interest, clinical adoption, and ultimately, patient impact from the outset.

Resvita Bio's CEO notes that in academia, scientists conduct numerous experiments to prove a single point for publication. In a startup, the focus shifts to building momentum. Once a concept is proven, the team must immediately move to the next challenge rather than over-verifying with redundant experiments.

Don't jump straight to building an MVP. The founders of unicorn Ada spent a full year working as customer support agents for other companies. This deep, immersive research allowed them to gain unique insights that competitors, who only had a surface-level idea, could never discover.

Many scientists are driven by pure curiosity. However, the mindset that pushes an academic toward entrepreneurship is a relentless focus on reaching a definitive conclusion—a 'yes or no' answer. This goal-oriented drive to translate a concept into a real-world application is a key founder trait in biotech.

Merrick Smela found the switch from academia to his startup, Ovelle, to be a small one. During his PhD, he operated with a clear, product-focused goal: "I want to make an egg." This contrasts the stereotype of purely exploratory academic research, showing that a mission-driven approach is excellent training for entrepreneurship.

A founder deep in the idea maze can articulate not just their current path, but also the alternatives they considered and why they were rejected. This demonstrates a profound understanding of their domain and problem space.